More about

Atopic Dermatitis

News
December 13, 2023
2 min read
Save

Interleukin-23 inhibitors exhibit lowest paradoxical eczema risk in psoriasis treatment

Interleukin-23 inhibitors exhibit lowest paradoxical eczema risk in psoriasis treatment

While certain demographic factors were associated with a higher risk for paradoxical eczema among patients with psoriasis, treatment with certain biologic classes was not, according to a study.

News
December 12, 2023
2 min read
Save

Greater atopic dermatitis severity linked to worse quality of life in pediatric patients

Greater atopic dermatitis severity linked to worse quality of life in pediatric patients

Pediatric patients with severe atopic dermatitis experienced higher rates of itch, pain, sleep disturbances and missed school days compared with those with mild disease, according to a study.

News
December 08, 2023
1 min read
Save

IMIDomics, Bristol Myers Squibb to research Sjögren's disease, atopic dermatitis

IMIDomics, Bristol Myers Squibb to research Sjögren's disease, atopic dermatitis

IMIDomics and Bristol Myers Squibb have expanded their partnership to include Sjögren's syndrome and atopic dermatitis in their research and development efforts for inflammatory diseases, the companies announced in a press release.

News
December 07, 2023
10 min listen
Save

Healio Minute Podcast, Dermatology Edition: Top Headlines - Week of December 4, 2023

Healio Minute Podcast, Dermatology Edition: Top Headlines - Week of December 4, 2023

In this edition, allergic illnesses in children may be inherited from mothers; addressing needs of Muslim patients in dermatology; YouTube content on topical steroid withdrawal exhibits poor reliability and more.

News
December 01, 2023
1 min read
Save

FDA accepts supplemental new drug application for roflumilast cream for atopic dermatitis

FDA accepts supplemental new drug application for roflumilast cream for atopic dermatitis

The FDA has accepted the supplemental new drug application for roflumilast cream 0.15% for adults and children aged as young as 6 years with atopic dermatitis, Arcutis Biotherapeutics announced in a press release.

CME
Multimedia

Moderate to Severe Atopic Dermatitis: When to Treat Versus When to Refer – A Wheel of Knowledge Challenge!

Moderate to Severe Atopic Dermatitis: When to Treat Versus When to Refer – A Wheel of Knowledge Challenge!
1.25 CME
1.25 AAFP
75 MINS
$0 FEE
News
November 28, 2023
2 min read
Save

Atopic dermatitis, other allergic illnesses in children may be inherited from mothers

Atopic dermatitis, other allergic illnesses in children may be inherited from mothers

Children born to mothers with atopic dermatitis are more prone to develop atopic dermatitis as well as other allergic illnesses, according to a study.

News
November 24, 2023
1 min read
Save

Top in allergy/asthma: Updates from the ACAAI Annual Scientific Meeting

Top in allergy/asthma: Updates from the ACAAI Annual Scientific Meeting

Research presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting showed that saltwater gargling and nasal rinsing were linked to lower hospitalization rates among patients with COVID-19.

News
November 22, 2023
2 min read
Save

Rademikibart maintains efficacy in atopic dermatitis through 1 year

Rademikibart maintains efficacy in atopic dermatitis through 1 year

Long-term trial results showed efficacy of rademikibart in Chinese patients with moderate to severe atopic dermatitis, Connect Biopharma announced in a press release.

News
November 18, 2023
1 min read
Save

European Commission approves Ebglyss for adults, adolescents with atopic dermatitis

European Commission approves Ebglyss for adults, adolescents with atopic dermatitis

The European Commission has approved Ebglyss in the European Union for the treatment of moderate to severe atopic dermatitis in adults and adolescents aged 12 years and older, Almirall announced in a press release.

View more